NEW YORK, Nov. 17 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
In 2008, the combined European biomaterial market was worth euro 271.4 million. This includes hyaluronic acid viscosupplements, bone graft substitutes, BMP growth factors, autologous chondrocyte implantation and platelet/bone marrow concentration systems. Within this report, the various bone grafting materials are examined, including autografted bone, allografts, demineralized bone and synthetic bone substitutes. The market across Europe is highly dependant on regulation, reimbursement and regional supply issues. Each of these has shaped the products of preference in each country, and understanding how they interact is a vital importance in providing orthopedic biomaterials to the European market. The European market encompasses Germany, France, Italy, United Kingdom (U.K.), Spain, Benelux (Belgium, the Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Switzerland, Austria, and Portugal.
To order this report:
Nicolas Bombourg Reportlinker Email: firstname.lastname@example.org US: (805)652-2626 Intl: +1 805-652-2626
Copyright©2009 PR Newswire.
All rights reserved